• Profile
Close

Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications

Annals of Rheumatic Diseases Feb 14, 2020

Kissel T, Reijm S, Slot LM, et al. - In this study, the cross-reactivity of monoclonal AMPA and the ability of different types of post-translational modification (PTM)-antigens to activate citrullinated proteins (CP)-reactive B-cell receptors (BCRs) were examined. BCR sequences from B cells isolated utilizing citrullinated or acetylated antigens were applied to deliver monoclonal antibodies (mAb) followed by a detailed analysis of their cross-reactivity towards PTM-antigens. While no reactivity was noted to the unmodified controls, most mAbs were highly cross-reactive towards multiple PTMs. Evidence showed that B cells carrying CP-reactive BCRs confirmed activation on stimulation with various types of PTM-antigens. This research demonstrates that AMPA exhibit a high cross-reactivity towards at least two PTMs showing that their recognition pattern is not limited to one type of modification. Moreover, the evidence display that CP-reactive B cells are not only activated by citrullinated, but also by carbamylated and/or acetylated antigens. These findings are essential for the belief of the breach of B-cell tolerance against PTM-antigens and the feasible contribution of these antigens to RA-pathogenesis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay